Guarini Kathryn
SEC insider (Form 3/4/5 filer). CIK 0001992352. Director at REGENERON PHARMACEUTICALS, INC. (REGN). 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in TARRYTOWN, NY.
Companies Guarini Kathryn has filed insider reports for
- REGENERON PHARMACEUTICALS, INC. (REGN): Director
Guarini Kathryn
CIK: 0001992352
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENERON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 2, 2026REGN
REGENERON PHARMACEUTICALS, INC.
ExerciseDirect400 shares at avg. $719.37$288K - Sep 2, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect400 shares at avg. $850.00$340K - Aug 10, 2026REGN
REGENERON PHARMACEUTICALS, INC.
ExerciseDirect400 shares at avg. $719.37$288K - Aug 10, 2026REGN
REGENERON PHARMACEUTICALS, INC.
SaleDirect400 shares at avg. $800.00$320K - Jan 2, 2026REGN
REGENERON PHARMACEUTICALS, INC.
AwardDirect155 shares- - Jan 2, 2025REGN
REGENERON PHARMACEUTICALS, INC.
AwardDirect166 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise | 400 | $719.37 | $287,748 | Direct |
| Sep 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 400 | $850.00 | $340,000 | Direct |
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Exercise | 400 | $719.37 | $287,748 | Direct |
| Aug 10, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Sale | 400 | $800.00 | $320,000 | Direct |
| Jan 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | Award | 155 | - | $0 | Direct |
| Jan 2, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Award | 166 | - | $0 | Direct |
1-6 of 6 transactions